Home LiteratureArticle Details
PMID: 12815156 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Spatial regulation of Galphai protein signaling in clathrin-coated membrane microdomains containing GAIP.

Molecular pharmacology ·Vol. 64 ·No. 1 ·2003-07-00 ·Pages 11-20

Elenko E, Fischer T, Niesman I, Harding T, McQuistan T, Von Zastrow M, Farquhar MG

Abstract

Regulators of G-protein signaling (RGS) proteins are GTPase-activating proteins (GAPs) that bind to Galpha subunits and attenuate G protein signaling, but where these events occur in the cell is not yet established. Here we investigated, by immunofluorescence labeling and deconvolution analysis, the site at which endogenous Galpha-interacting protein (GAIP) (RGS19) binds to Galphai3-YFP and its fate after activation of delta-opioid receptor (DOR). In the absence of agonist, GAIP is spatially segregated from Galphai3 and DOR in clathrin-coated domains (CCPs) of the cell membrane (PM), whereas Galphai3-YPF and DOR are located in non-clathrin-coated microdomains of the PM. Upon addition of agonist, Galphai3 partially colocalizes with GAIP in CCPs at the PM. When endocytosis is blocked by expression of a dynamin mutant [dyn(K44A)], there is a striking overlap in the distribution of DOR and Galphai3-YFP with GAIP in CCPs. Moreover, Galphai3-YFP and GAIP form a coprecipitable complex. Our results support a model whereby, after agonist addition, DOR and Galphai3 move together into CCPs where Galphai3 and GAIP meet and turn off G protein signaling. Subsequently, Galphai3 returns to non-clathrin-coated microdomains of the PM, GAIP remains stably associated with CCPs, and DOR is internalized via clathrin-coated vesicles. This constitutes a novel mechanism for regulation of Galpha signaling through spatial segregation of a GAP in clathrin-coated pits.

MeSH Terms
Adaptor Protein Complex 2/metabolism Bacterial Proteins/chemistry Cells, Cultured Clathrin/metabolism Coated Vesicles/metabolism Dynamins/metabolism Endosomes/metabolism GTP-Binding Protein alpha Subunits, Gi-Go GTP-Binding Proteins/metabolism GTPase-Activating Proteins/metabolism Heterotrimeric GTP-Binding Proteins/metabolism Humans Luminescent Proteins/chemistry Membrane Microdomains/metabolism Phosphoproteins/genetics,metabolism RGS Proteins Receptors, Opioid, delta/metabolism Signal Transduction/physiology
Chemicals
Adaptor Protein Complex 2 Bacterial Proteins Clathrin GTPase-Activating Proteins Luminescent Proteins Phosphoproteins RGS Proteins Receptors, Opioid, delta regulator of G-protein signalling 19 yellow fluorescent protein, Bacteria GTP-Binding Proteins GNAI3 protein, human GTP-Binding Protein alpha Subunits, Gi-Go Heterotrimeric GTP-Binding Proteins Dynamins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Elenko Eric
Department of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0651, USA.
Fischer Thierry
Niesman Ingrid
Harding Tim
McQuistan Tammie
Von Zastrow Mark
Farquhar Marilyn G
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
2003-07-00
Pages
11-20
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NCI NIH HHS · CA58689 · United States
NCI NIH HHS · CA67754 · United States
NIDDK NIH HHS · DK17780 · United States
NHLBI NIH HHS · HL0726 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com